SCHEDULE 13D/A: Saba Capital Reduces Stake in Nuveen New Jersey Quality Municipal Income Fund to 10.23%
Amendment to Schedule 13D
Saba Capital Management, L.P. has filed an Amendment No. 15 to its Schedule 13D, disclosing a reduction in its beneficial ownership of Nuveen New Jersey Quality Municipal Income Fund to 10.23% through open market sales.
Summary
- Saba Capital Management, L.P., along with Saba Capital Management GP, LLC and Mr. Boaz R. Weinstein (collectively, the "Reporting Persons"), filed an Amendment No. 15 to Schedule 13D.
- The filing updates their beneficial ownership in Nuveen New Jersey Quality Municipal Income Fund (the "Issuer").
- As of March 7, 2025, the Reporting Persons beneficially own 4,217,640 common shares, representing 10.23% of the Issuer's outstanding common shares.
- This percentage is calculated based on 41,232,935 common shares outstanding as of August 31, 2024, as disclosed in the Issuer's N-CSR filed on November 8, 2024.
- The amendment details open market sales of a total of 487,145 common shares by Saba Capital between February 11, 2025, and March 7, 2025.
- These sales occurred at prices ranging from $12.09 to $12.32 per share.
- Approximately $47,828,997 was paid to acquire the total common shares reported by the Reporting Persons, funded by investor subscription proceeds, capital appreciation, and margin account borrowings.
Sentiment
Score: 4
Explanation: The document reports a reduction in beneficial ownership by a significant institutional investor through open market sales. While not explicitly negative, a reduction in stake by an activist investor can be perceived as a lack of conviction or profit-taking, which might lead to negative market sentiment for the issuer's shares.
Future Outlook
NA
Industry Context
This filing reflects a significant institutional investor's (Saba Capital, known for activist investing in closed-end funds) adjustment of its position in a municipal income fund. Such adjustments can be driven by portfolio rebalancing, profit-taking, or a change in outlook on the specific fund or the broader municipal bond market. The sale of shares by a large holder like Saba Capital could be interpreted by the market as a signal, though the specific reasons are not disclosed in this filing.
Stakeholder Impact
- Shareholders: The reduction in Saba Capital's stake could lead to decreased investor confidence or downward pressure on the share price, especially if other investors interpret it as a negative signal.
Key Dates
| Date | Description |
|---|---|
| 2015-11-16 | Date of power of attorney for signature by Boaz R. Weinstein. |
| 2015-12-28 | Date of initial Schedule 13G filing by the Reporting Persons. |
| 2024-08-31 | Date as of which 41,232,935 common shares were outstanding, used for percentage calculation. |
| 2024-11-08 | Date Nuveen New Jersey Quality Municipal Income Fund's N-CSR was filed, disclosing shares outstanding. |
| 2025-02-11 | Start date of reported open market share sales by Saba Capital. |
| 2025-03-07 | Date of event which required the filing of this Schedule 13D/A (last reported sale date). |
| 2025-03-11 | Date of signing of this Schedule 13D/A. |
Recommendation
holdKeywords
Saba Capital Management, Nuveen New Jersey Quality Municipal Income Fund, Schedule 13D/A, Beneficial Ownership, SEC Filing, Closed-End Fund, Investment Management, Share Sales, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.